Smart Products

TMCNet:  The SI Report: Covidien Announces Acquisition of Specialty Injection 
Devices from Pinyons Medical Technology, Inc.

[May 15, 2008]

The SI Report: Covidien Announces Acquisition of Specialty Injection Devices from Pinyons Medical Technology, Inc.

(M2 PressWIRE Via Acquire Media NewsEdge)
RDATE:15052008

Streetinvesting.com has now resumed our progressive Covidien, Ltd.
(NYSE:COV) as it opened up $0.09 nearing its 52 week high of $49.70 on
a much higher than average volume midday trading Wednesday, May 14,
2008. Based on the Company's most recent news release; we will be
progressively reviewing the impact of the markets and the effects of
their developments. We will be providing updates and analyst opinions
as new stories unfold.

Make sure to visit www.streetinvesting.com to keep updated and signup
for free with no credit card for market reports and analytical plays.

Our research resources have been aimed towards the US Large Caps and
the various prospective companies therein Covidien, Ltd. was among
those that we have been closely examining due to their recent news and
trading patterns. Sign up at www, streetinvesting.com for more
information on the company mentioned herein.

May 14, 2008, -- Covidien, a leading global provider of healthcare
products, announced that it has signed an agreement with Pinyons
Medical Technology Inc., a privately-held company based in Park City,
Utah, and its President and CEO, Shawn Fojtik, to acquire all assets
related to the Pinyons POWRSyringe Injector and POWRSyringe Monitor
handheld, manual injection and inflation devices. These devices
facilitate manual x-ray contrast media injections during angiography
procedures performed in the cardiac catheterization laboratory and
interventional radiology suite.

Covidien is a leading global healthcare products company that creates
innovative medical solutions for better patient outcomes and delivers
value through clinical leadership and excellence. Covidien
manufactures, distributes and services a diverse range of
industry-leading product lines in four segments: Medical Devices,
Imaging Solutions, Pharmaceutical Products and Medical Supplies. With
2007 revenue of nearly $9 billion, Covidien has more than 42,000
employees worldwide in 57 countries, and its products are sold in over
130 countries. Please visit www.covidien.com to learn more about our
business.

Streetinvesting.com will continue to follow the progress of this
company following their most recent news announcement. Visit
www.streetinvesting.com and signup free for our financial market
services.

At Streetinvesting.com, we bring our knowledge of the marketplace and
investment opportunities directly to our subscribers. As an
aggressive-growth research company, our strength and goal is bringing
distinctive trading opportunities and investment philosophies to
investors seeking a different and unique approach to investment ideas.
That's our goal. That's what we do. We are "The Word on the Street".

Let us become your number one portal for research and information on
the global markets.

To continue with the more in-depth analysis, please visit
www.streetinvesting.com for a complimentary subscription to access this
report and other related articles. Please note that membership does not
require credit card information.

All material herein was prepared by Streetinvesting.com, (Street
Investing) based upon information believed to be reliable. The
information contained herein is not guaranteed by Streetinvesting.com
to be accurate, and should not be considered to be all-inclusive. The
companies that are discussed in this opinion have not approved the
statements made in this opinion. This opinion contains forward-looking
Story continues below ↓
statements that involve risks and uncertainties. This material is for
informational purposes only and should not be construed as an offer or
solicitation of an offer to buy or sell securities. Streetinvesting.com
is not a licensed broker, broker dealer, market maker, investment
banker, investment advisor, analyst or underwriter. Please consult a
broker before purchasing or selling any securities viewed on or
mentioned herein. Streetinvesting.com may receive compensation in cash
or shares from independent third parties or from the companies
mentioned.

Streetinvesting.com's affiliates, officers, directors and employees may
also have bought or may buy the shares discussed in this opinion and
may profit in the event those shares rise in value.

Streetinvesting.com will not advise as to when it decides to sell and
does not and will not offer any opinion as to when others should sell;
each investor must make that decision based on his or her judgment of
the market.

This release contains "forward-looking statements" within the meaning
of Section 27A of the Securities Act of 1933, as amended, and Section
21E the Securities Exchange Act of 1934, as amended and such
forward-looking statements are made pursuant to the safe harbor
provisions of the Private Securities Litigation Reform Act of 1995.
"Forward-looking statements" describe future expectations, plans,
results, or strategies and are generally preceded by words such as
"may", "future", "plan" or "planned", "will" or "should", "expected,"
"anticipates", "draft", "eventually" or "projected". You are cautioned
that such statements are subject to a multitude of risks and
uncertainties that could cause future circumstances, events, or results
to differ materially from those projected in the forward-looking
statements, including the risks that actual results may differ
materially from those projected in the forward-looking statements as a
result of various factors, and other risks identified in a companies'
annual report on Form 10-K or 10-KSB and other filings made by such
company with the Securities and Exchange Commission.

You should consider these factors in evaluating the forward-looking
statements included herein, and not place undue reliance on such
statements. The forward-looking statements in this release are made as
of the date hereof and Streetinvesting.com undertakes no obligation to
update such statements.

CONTACT: Streetinvesting.com
WWW: http://www.streetinvesting.com

((M2 Communications Ltd disclaims all liability for information
provided within M2 PressWIRE. Data supplied by named party/parties.
Further information on M2 PressWIRE can be obtained at
http://www.presswire.net on the world wide web. Inquiries to
info@m2.com)).

Copyright ? 2008 M2 Communications Ltd.

[ Back To Smart Product Home's Homepage ]